Presentation TCT 2017 Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani October 30, 2017
Presentation TCT 2017 Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective Presenter: Stephen G. Ellis, David E. Kandzari, Sigmund Silber October 30, 2017
Presentation TCT 2017 When Two Stents Are Indicated: TAP Technique Step-by-step (With Case Examples) Presenter: Terje K. Steigen, Leif Thuesen, Francesco Burzotta October 30, 2017
Presentation TCT 2017 When Two Stents Are Indicated: Culotte Technique Step-by-step (With Case Examples) Presenter: Terje K. Steigen, Leif Thuesen, Ioannis Iakovou October 30, 2017
Presentation TCT 2017 XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT Presenter: Stephen G. Ellis, David E. Kandzari, Tullio Palmerini October 30, 2017
Presentation TCT 2017 Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein October 30, 2017
Presentation TCT 2017 Techniques for Side Branch Bailout Stent Use When the Provisional Approach Fails Presenter: Terje K. Steigen, Leif Thuesen, Vladimir Dzavik October 30, 2017
Presentation TCT 2017 Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It? Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran October 30, 2017
Presentation TCT 2017 My Stepwise Approach to Bifurcations to Decide Between 1 and 2 Stents (With Case Examples) Presenter: Terje K. Steigen, Leif Thuesen, Yves R. Louvard October 30, 2017
Presentation TCT 2017 Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry Presenter: Dean J. Kereiakes, Spencer B. King III, Ian T. Meredith October 30, 2017
Presentation TCT 2017 Bifurcation Stents 1: TRYTON Description, Data, and Case Examples Presenter: Alaide Chieffo, Jeffrey W. Moses, Philippe Genereux October 30, 2017
Presentation TCT 2017 Impact of Mandatory Stent Price Controls 1: Physician Perspectives Presenter: Dean J. Kereiakes, Spencer B. King III, Upendra Kaul October 30, 2017
Presentation TCT 2017 Treatment of Coronary Bifurcations in the Contemporary Era of P2Y12 Inhibitors and "Biologically Active Stents" Presenter: Davide Capodanno, David Hildick-Smith, Marco Zimarino October 30, 2017
Presentation TCT 2017 Impact of AUC and Public Reporting: Is PCI Now More Appropriate? Presenter: Dean J. Kereiakes, Spencer B. King III, Michael A. Kutcher October 30, 2017
Presentation TCT 2017 Bifurcation Stents 4: NILE Description, Data, and Case Examples Presenter: Alaide Chieffo, Jeffrey W. Moses, Ivo Petrov October 30, 2017
Presentation TCT 2017 Bifurcation Stents 3: BIOSS Description, Data, and Case Examples Presenter: Alaide Chieffo, Jeffrey W. Moses, Ricardo A. Costa October 30, 2017
Presentation TCT 2017 Memorial Lecture: What the Medina Classification Has Meant to Me and the Field of Bifurcation Stenting Presenter: Davide Capodanno, David Hildick-Smith, Antonio Colombo October 30, 2017
Presentation TCT 2017 Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development? Presenter: Dean J. Kereiakes, Spencer B. King III, Elazer R. Edelman October 30, 2017
Presentation TCT 2017 Bifurcation Stents 2: AXXESS Plus Description, Data, and Case Examples Presenter: Alaide Chieffo, Jeffrey W. Moses, Fausto Feres October 30, 2017
Presentation TCT 2017 Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease? Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Christophe Dubois October 30, 2017